Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by coalbeton Jan 19, 2018 1:25pm

75 Views

Post# 27395363

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:12-billion $ deal, this could be us?

MACMAN TAKE NOTE OUTSTANDING SHARES SHARE PRICE X7

Apple Inc. (AAPL) shares fell and closed the day at $153.61, with the percent change of -0.17%. The company has its outstanding shares of 5.23 Billion. A total of 21.88 Million shares exchanged at hands and its Average Volume (3 months) is 24.87 Million. Its 52-week high and low range is $56.65 and $91.50, respectively. The company has a market cap of $802.73 Billion.

Bullboard Posts

Advancing flagship Ishkõday Gold Project in Ontario